fbpx
Skip to content

Donald Trump Criticizes Suspension of Johnson & Johnson Vaccine

suspensión de la vacunación, El American

Leer en Español

[Leer en español]

Former President Donald Trump criticized on Tuesday the suspension of Johnson & Johnson’s vaccination doses. Trump argued that the situation will now generate distrust in citizens about the COVID-19 vaccine.

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) will announce that administration of the drug is suspended to investigate whether 6 thrombus cases are linked to the vaccine.

“Biden’s administration did a terrible disservice to people thoughout the world by allowing the FDA and CDC to call a pause in the use of the Johnson & Johnson’s COVID-19 vaccine,” Trump said in a statement.

The Republican stressed that the benefits of the vaccine outweigh the risks of developing adverse effects. In addition, he hinted that the measure could respond to political issues. He indicated that now Americans vaccinated with Johnson & Johnson’s vaccine will be on the alert.

“The results of this vaccine have been extraordinary, but now its reputation will be permanently challenged. The people who have already been vaccinated will be up in arms, and perhaps this was all done for political reasons or perhaps it’s the FDA’s love for Pfizer,” he said.

johnson
The suspension of the vaccination was due to rare cases of clotting, the FDA said (EFE).

Vaccination suspension

One woman died and another is in serious condition among the six cases of the alleged adverse reaction to the Johnson & Johnson vaccine, which led to the government’s decision to halt vaccinations.

This was stated by officials from the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) who appeared at a press conference on Tuesday following the announcement of a pause in the use of this vaccine.

According to the FDA, as of Monday, at least 6.8 million Americans have been vaccinated with the Johnson & Johnson doses. In addition, the drug agency said it is evaluating six rare cases of coagulation. Likewise, it described the cases as “extremely rare.”

“Of a rare and serious type of blood clot in individuals after receiving the vaccine. At this time, these adverse events appear to be extremely rare.”

Leave a Reply

Total
0
Share